Fenitoína Hikma

Fenitoína Hikma is a pharmaceutical product containing phenytoin sodium, used for managing certain types of seizures. This intravenous medication is manufactured by Hikma Farmacêutica (Portugal), S.A. and is suitable for patients requiring seizure control.

Fenitoína Hikma is primarily used for the treatment of seizures, including tonic-clonic seizures and other types of epilepsy. It works by stabilizing electrical activity in the brain, helping to prevent or reduce the frequency of seizures. This medication is often prescribed when other treatments have not been effective or are not suitable.

Common effects of Fenitoína Hikma may include dizziness, drowsiness, and coordination problems. Some users may experience nausea or vomiting. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Fenitoína Hikma should be used with caution in patients with a history of heart disease, liver disease, or porphyria. It is important to follow the prescribed dosage and administration instructions carefully. This medication should not be stopped abruptly without consulting a healthcare provider.

Fenitoína Hikma may interact with other medications, including antacids, anticoagulants, and certain antibiotics. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided while using this medication.